The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Actinium Pharmaceuticals; BioNTech; Chimerix; Formycon; Sustained Therapeutics; Teladoc; Telix Pharmaceuticals; UroGen pharma
Research Funding - Advanced Accelerator Applications/Novartis; Amgen; Mariana
Patents, Royalties, Other Intellectual Property - Sustained Therapeutics
Travel, Accommodations, Expenses - Amgen; Bayer
Prognostic PSMA-PET PROMISE nomograms for patients with prostate cancer.
 
Wolfgang Peter Fendler
Honoraria - Parexel
Consulting or Advisory Role - Calyx; Janssen
Speakers' Bureau - ABX Advanced biochemical compounds; Amgen; Bayer; Eczacibasi Monrol; GE Healthcare; Janssen; Novartis; Telix Pharmaceuticals
Research Funding - SOFIE
 
Madeleine J. Karpinski
No Relationships to Disclose
 
Johannes Hüsing
No Relationships to Disclose
 
Kevin Claassen
Employment - MVZ Dr. Eberhard und Partner Dortmund GbR (I)
 
Lennart Möller
Employment - Boehringer Ingelheim
 
Hiltraud Kajüter
No Relationships to Disclose
 
Florian Oesterling
No Relationships to Disclose
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Genmab; MSD
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; PCI Biotech; Pfizer; Synthekine
Research Funding - Amgen (Inst); Bicycle Therapeutics (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Merck Serono; Pfizer
 
Lale Umutlu
Leadership - Bayer; Easy Radiology; Siemens Healthineers
Honoraria - Bayer; Easy Radiology; Siemens Healthineers
Consulting or Advisory Role - Bayer; Easy Radiology; Siemens Healthineers
Speakers' Bureau - Bayer; Easy Radiology; Siemens Healthineers
Research Funding - Siemens Healthineers
Travel, Accommodations, Expenses - Bayer; Easy Radiology; Siemens Healthineers
 
Helena Lanzafame
No Relationships to Disclose
 
Tugce Telli
Speakers' Bureau - Advanced Biochemical Compounds
Research Funding - DAAD Research Grant
 
Anja Merkel-Jens
No Relationships to Disclose
 
Anika Hüsing
No Relationships to Disclose
 
Claudia Kesch
No Relationships to Disclose
 
Ken Herrmann
Leadership - Pharma15; SOFIE; Theragnostics
Stock and Other Ownership Interests - AdvanCell; Aktis Oncology; Convergent Therapeutics; Pharma15; SOFIE; Theragnostics
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bain Capital; Bayer; Boston Scientific; BTG; Debiopharm Group; Fusion Pharmaceuticals; GE Healthcare; Immedica; IPSEN; ITG (Inst); Janssen Oncology; Molecular Partners; Novartis; Radiopharm Theranostics; ROTOP Pharmaka (Inst); Siemens Healthineers; Telix Pharmaceuticals
 
Andreas Stang
No Relationships to Disclose
 
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Accord Healthcare; Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Lightpoint medical; Merck KGaA; MSD; Novartis; Onkowissen; Pfizer; POINT Biopharma
Research Funding - Bristol Myers Squibb (Inst); Janssen; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; Ipsen; Janssen